Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Privacy Lost: How the Government Deleted Bill C-11’s Key Privacy Principle Just Two Months After Passing it Into Law 
Out of Nowhere: TIFF Undermines Artistic Freedom of Expression With Forced Name Change of October 7th Documentary 
TIFF Removes October 7th Documentary Film From Schedule Citing Implausible Copyright Clearance Concerns From Hamas Terror Footage 
Carney’s Digital Recalibration: How the Government is Trending Away from Justin Trudeau’s Digital Policy 
Let Competition Be the Guide: Why the Government and CRTC Got It Right on Wholesale Fibre Broadband Access
